153 related articles for article (PubMed ID: 20421536)
1. Improving prostate-specific antigen screening.
Strope SA; Andriole GL
J Clin Oncol; 2010 May; 28(15):2491-2. PubMed ID: 20421536
[No Abstract] [Full Text] [Related]
2. Editorial for "Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50".
Andriole GL; Kibel AS
Cancer; 2011 Mar; 117(6):1110-2. PubMed ID: 20960524
[No Abstract] [Full Text] [Related]
3. Other methods for improved prostate cancer detection?
Printz C
Cancer; 2012 May; 118(9):2337. PubMed ID: 22522609
[No Abstract] [Full Text] [Related]
4. Advances in the application of prostate-specific antigen in the detection of early-stage prostate cancer.
Kamoi K; Babaian RJ
Semin Oncol; 1999 Apr; 26(2):140-9. PubMed ID: 10597725
[TBL] [Abstract][Full Text] [Related]
5. Perspective on prostate cancer screening.
Rogers CS
Int J Clin Pract; 2011 Jan; 65(1):31-4. PubMed ID: 21155942
[No Abstract] [Full Text] [Related]
6. Prostate cancer screening and mortality: comparison of recent randomized controlled clinical trials.
Mian BM
Urol Oncol; 2010; 28(3):233-6. PubMed ID: 20097584
[No Abstract] [Full Text] [Related]
7. [Reliability and use of prostate-specific antigen in the management of patients with prostatic cancer].
Hübler J; Jávor A
Orv Hetil; 1993 Jul; 134(28):1529-32. PubMed ID: 7688112
[TBL] [Abstract][Full Text] [Related]
8. The economic impact of prostate cancer screening and treatment.
DiSantostefano RL; Lavelle JP
N C Med J; 2006; 67(2):158-60. PubMed ID: 16752723
[No Abstract] [Full Text] [Related]
9. Strategies combining total and percent free prostate specific antigen for detecting prostate cancer: a prospective evaluation.
Gann PH; Ma J; Catalona WJ; Stampfer MJ
J Urol; 2002 Jun; 167(6):2427-34. PubMed ID: 11992051
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen in screening for prostate cancer.
Mayer FJ; Crawford ED
West J Med; 1994 Feb; 160(2):168. PubMed ID: 7512780
[No Abstract] [Full Text] [Related]
11. Update on screening for prostate cancer with prostate-specific antigen.
Schmid HP; Riesen W; Prikler L
Crit Rev Oncol Hematol; 2004 Apr; 50(1):71-8. PubMed ID: 15094160
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer screening "reloaded".
Gomella LG
Can J Urol; 2010 Apr; 17(2):5057. PubMed ID: 20398441
[No Abstract] [Full Text] [Related]
13. A practical guide to prostate cancer diagnosis and management.
Simmons MN; Berglund RK; Jones JS
Cleve Clin J Med; 2011 May; 78(5):321-31. PubMed ID: 21536828
[TBL] [Abstract][Full Text] [Related]
14. Two large trials show prostate screening has limited reduction in mortality.
Printz C
Cancer; 2012 Apr; 118(8):1960. PubMed ID: 22488667
[No Abstract] [Full Text] [Related]
15. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.
Belpomme D; Irigaray P
J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186
[No Abstract] [Full Text] [Related]
16. Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendees.
Bergdahl AG; Aus G; Lilja H; Hugosson J
Cancer; 2009 Dec; 115(24):5672-9. PubMed ID: 19813273
[TBL] [Abstract][Full Text] [Related]
17. The PSA position.
Nature; 2011 Oct; 478(7369):286. PubMed ID: 22012348
[No Abstract] [Full Text] [Related]
18. [Clinical significance of prostate-specific antigen].
Tveter KJ; Otnes B
Tidsskr Nor Laegeforen; 1994 Jan; 114(2):160-2. PubMed ID: 7510073
[TBL] [Abstract][Full Text] [Related]
19. [Prostate cancer and prostate specific antigen screening].
Camici M
Minerva Med; 2004 Feb; 95(1):25-34. PubMed ID: 15041924
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer screening; is this a teachable moment?
Brawley OW
J Natl Cancer Inst; 2009 Oct; 101(19):1295-7. PubMed ID: 19720970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
